OMAXE NSE filing

Omaxe Limited: SAT Dismisses Appeal Against SEBI Order

The RealCase readMedium impact Neutral

Omaxe Limited's appeal against a SEBI order has been dismissed by the Securities Appellate Tribunal (SAT). The SAT's order dated September 1, 2026, dismissed the appeal filed against SEBI's July 30, 2024 order. The company is evaluating the order and its remedies.

Why it matters

The dismissal of an appeal against a SEBI order can have implications for the company's regulatory standing and future operations, even if no immediate additional financial impact is stated. It confirms the initial SEBI order, which could have underlying consequences.

The market read

The SAT dismissed the appeal against the SEBI order. While this confirms the SEBI order, the company is evaluating its options and states there is no additional material financial or operational impact, suggesting a neutral outcome for now.

Omaxe Limited has announced that the Hon'ble Securities Appellate Tribunal (SAT) has pronounced its Order dated September 1, 2026, dismissing the appeal filed by the company and certain individuals against an order passed by the Securities and Exchange Board of India (SEBI) on July 30, 2024.

The SAT's order also disposes of any pending interlocutory applications without awarding costs. The company is currently evaluating the SAT's order and its available legal remedies.

The allegations, as previously disclosed by Omaxe Limited on July 31, 2024, pertain to alleged violations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Listing Agreement, SEBI (Prohibition of Fraudulent and Unfair Trade Practices relating to Securities Market) Regulations, 2003, SEBI Act, 1992, Companies Act, 2013, and applicable Accounting Standards.

The company stated that the SAT's order does not have any additional material impact on its financial, operational, or other activities beyond what was already disclosed in relation to the SEBI order dated July 30, 2024.

Primary source

A plain-language summary of a public exchange filing by Omaxe Limited. Read the original for the full detail.

View original filing
This is RealCase

Every move, explained.

Expert model portfolios with exact weights, an Active or Hold state on every holding, and a written reason behind every change. In your pocket.

Coming soon toApp StoreComing soon toGoogle Play
100% digital · your money stays in your own broker · your data is secure
RealCase
Your RealCases
Core Compounders
Stocks
13.4%
Flexi Core
Mutual Funds
13.1%
Latest change
ActiveHDFC Bank10% → 14%

“Deposits growing faster than loans again. We add on strength, funded from cash.”

₹0Commission · fee-only